206 related articles for article (PubMed ID: 6432017)
1. Clinical results obtained from a new controlled release theophylline preparation.
Nolte D
Br J Clin Pract Suppl; 1984; 32():14-7. PubMed ID: 6432017
[No Abstract] [Full Text] [Related]
2. [Results of a serum concentration-oriented dosage of a theophylline depot preparation in ambulatory patients with chronic obstructive lung disease].
Harder S; Staib AH; Stauder J
Prax Klin Pneumol; 1985 Jun; 39(6):193-6. PubMed ID: 4022931
[No Abstract] [Full Text] [Related]
3. The tolerability of a new oral controlled release theophylline preparation in patients with obstructive airways diseases.
Nolte D; Dusik B
Br J Clin Pract Suppl; 1984; 32():18-21. PubMed ID: 6432018
[No Abstract] [Full Text] [Related]
4. [Clinical functional study of a new delayed-action preparation of "once a day" anhydrous theophylline in patients with chronic obstructive bronchopneumopathy].
Gatto PG; Bruzzoni A; Valenti V
Clin Ter; 1989 Jul; 130(1):45-9. PubMed ID: 2529079
[TBL] [Abstract][Full Text] [Related]
5. [Use of a new delayed-release anhydrous theophylline by single daily administration in the treatment of reversible bronchial obstruction. Comparison with a delayed-release preparation administered twice daily].
Baronti A; Verdiani P; Di Carlo S
Clin Ter; 1987 Sep; 122(6):437-40. PubMed ID: 2972456
[No Abstract] [Full Text] [Related]
6. Comparison of standard- and sustained-release theophylline tablets in patients with chronic obstructive pulmonary disease.
Dasta J; Mirtallo JM; Altman M
Am J Hosp Pharm; 1979 May; 36(5):613-7. PubMed ID: 453214
[No Abstract] [Full Text] [Related]
7. [Treatment of chronic obstructive respiratory disease with a new purified theophylline preparation in delayed-action form].
Kaik G
Wien Med Wochenschr; 1984 Apr; 134(7):163-9. PubMed ID: 6741156
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the effectiveness and safety of a controlled-release theophylline in patients with reversible and stable bronchial obstruction.
Grassi V; Nicora M; Beretta A
Int J Clin Pharmacol Res; 1987; 7(5):337-44. PubMed ID: 3667006
[TBL] [Abstract][Full Text] [Related]
9. [Optimizing therapy with theophylline preparations in obstructive ventilation disorders. 3. Prediction of theophylline clearance with a simple pharmacokinetic method and comparison of bioavailability of various theophylline retard preparations].
Ranke C; Schmidt G; Oellerich M; Sybrecht GW
Prax Klin Pneumol; 1983 Mar; 37(3):99-108. PubMed ID: 6856564
[No Abstract] [Full Text] [Related]
10. [Clinico-laboratory evaluation a new sustained-release preparation of anhydrous theophylline].
Gandola L; Aiolfi S; Soccini F; Patrini G; Capellini G; Scartabellati A; Ghio L; Mauri F
Clin Ter; 1989 Dec; 131(5):293-7. PubMed ID: 2532583
[TBL] [Abstract][Full Text] [Related]
11. The use of sustained-release theophylline ('Theo-dur') for the treatment of chronic reversible obstructive lung disease in hospital practice.
Riddington CJ; Shipman AJ
Br J Clin Pract; 1985 Apr; 39(4):148-53. PubMed ID: 3893504
[No Abstract] [Full Text] [Related]
12. [Obstructive airway diseases. Basic therapy with pure theophylline in retard form].
Pollert I
Fortschr Med; 1982 Mar; 100(12):547-50. PubMed ID: 7042500
[No Abstract] [Full Text] [Related]
13. [Therapy of obstructive respiratory tract diseases. Study of afonilum retard in 3,512 patients].
Eichhorn J; Perré R
Med Welt; 1982 Dec; 33(50):1834-7. PubMed ID: 6762480
[No Abstract] [Full Text] [Related]
14. [Tolerance of a new oral long-acting theophylline in patients with obstructive airway diseases].
Nolte D; Dusik B
Fortschr Med; 1983 Jul; 101(25):1203-6. PubMed ID: 6884955
[TBL] [Abstract][Full Text] [Related]
15. The use of parenteral aminophylline in patients taking slow release theophylline preparations: an observation of clinical practice.
Arbab OA; Wiggins J; Ayres JG; Stableforth DE
Br J Dis Chest; 1985 Apr; 79(2):161-71. PubMed ID: 3986120
[TBL] [Abstract][Full Text] [Related]
16. Combined administration of controlled release theophylline and ranitidine: a 53-day controlled survey in patients with chronic obstructive lung disease (COLD) and peptic disease.
Dal Negro R; Turco P; Pomari C; Trevisan F; De Conti F; Cordaro CI
Br J Clin Pract; 1987 Nov; 41(11):1004-8. PubMed ID: 3504314
[No Abstract] [Full Text] [Related]
17. Rifampicin-isoniazid and delayed elimination of theophylline: a case report.
Dal Negro R; Turco P; Trevisan F; De Conti F
Int J Clin Pharmacol Res; 1988; 8(4):275-7. PubMed ID: 3182118
[TBL] [Abstract][Full Text] [Related]
18. [Treatment of obstructive respiratory disorders using a new theophylline retard preparation].
Schroers M; Merbach W; Don M
ZFA (Stuttgart); 1982 Jun; 58(17):974-8. PubMed ID: 7113392
[No Abstract] [Full Text] [Related]
19. Slow release theophylline in patients with airways obstruction with particular reference to the effects of food upon serum levels.
Thompson PJ; Kemp MW; McAllister WA; Turner-Warwick M
Br J Dis Chest; 1983 Jul; 77(3):293-8. PubMed ID: 6351891
[TBL] [Abstract][Full Text] [Related]
20. [Levels of blood theophylline in patients with acute bronchospasm].
Martínez MJ; Martínez B; Saucedo R; García Delgado R; García Morillas M; Puche E
Rev Clin Esp; 1989 May; 184(9):470-2. PubMed ID: 2772324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]